FDA Should Call Last Round For OTC Hangover Indication, Cmte. Suggests

Comments from the Nonprescription Drug and the Drug Safety and Risk Management advisory committees during a joint meeting could push US FDA toward pulling the plug on hangover as a monograph indication.